|
- 2016
IL-25通过nuocyte细胞诱导哮喘小鼠气道重塑
|
Abstract:
[1] | Holgate ST. Pathogenesis of Asthma[J]. Clin Exp Allergy, 2008, 38(6):872-897. |
[2] | Hurst SD, Muchamuel T, Gorman DM, et al. New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25[J]. Immunol, 2002, 169(1):443-453. |
[3] | Pan G, French D, Mao W, et al. Forced expression of murine IL-17E induces growth retardation, jaundice, a Th2-biased response, and multiorgan inflammation in mice[J]. Immunol, 2001, 167(11):6559-6567. |
[4] | Gregory LG, Jones CP, Walker SA, et al. IL-25 drives remodelling in allergic airways disease induced by house dust mite[J]. Thorax, 2013, 68(1):82-90. |
[5] | Ballantyne SJ, Barlow JL, Jolin HE, et al. Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma[J]. Allergy Clin Immunol, 2007, 120(6):1324-1331. |
[6] | Yao XJ, Huang KW, Li Y, et al. Direct comparison of the dynamics of IL-25-and‘allergen’-induced airways inflammation, remodelling and hypersensitivity in a murine asthma model[J]. Clin Exp Allergy, 2014, 44(5):765-777. |
[7] | Caruso R, Sarra M, Stolfi C, et al. Interleukin-25 inhibits interleukin-12 production and Th1 celldriven inflammation in the gut[J]. Gastroenterology, 2009, 136(7):2270-2279. |
[8] | Kim JH, Jang YS, Eom KS, et al. Transforming growth factor beta1 induces epithelial- to-mesenchymal transition of A 549 cell[J]. Korean Med Sci, 2007, 22(5):898-904. |
[9] | Angkasekwinai P, Park H, Wang YH, et al. Interleukin 25 promotes the initiation of Poallergic type 2 responses[J]. Exp Med, 2007, 204(7):1509-1517. |
[10] | Camelo A, Barlow JL, Drynan LF, et al. Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13[J]. J Gastroenterol, 2012, 47(11):1198-1211. |
[11] | 刘粉,吴金香,赵继萍,等.气道上皮IL-25促进哮喘气道重塑[J]. 细胞与分子免疫学杂志, 2012, 28(6): 633-636. LIU Fen, WU Jinxiang, ZHAO Jiping, et al. IL-25 derived from epithelial cells has the potential to promote airway remodeling in asthma[J]. Chin J Cell Mol Immunol, 2012, 28(6):633-636. |
[12] | Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity[J]. Nature, 2010, 464(7293):1367-1370. |
[13] | Honda K, Marquillies P, Capron M, et al. Peroxisome proliferator-activated receptor gamma is expressed in airways and inhibits features of airway remodeling in a mouse asthma model[J]. Allergy Clin Immunol, 2004, 113(5):882-888. |
[14] | Barlow JL, Bellosi A, Hardman CS, et al. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity[J]. Allergy Clin Immunol, 2012, 129(1):191-198. |
[15] | 朱艳芬,宋泽庆.哮喘小鼠气道重塑中α平滑肌肌动蛋白的表达[J]. 中国免疫学杂志, 2011, 27(10):934-941. ZHU Yanfen, SONG Zeqing. The expressions of α-SMA in airway remodeling model of bronchial asthma in mouse[J]. Chinese Journal of Immunology, 2011, 27(10):934-941. |
[16] | Fort MM, Cheung J, Yen D, et al. IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo[J]. Immunity, 2001, 15(6):985-995. |